Stay updated on Safety and Immunogenicity of VLA2001 in Adults Aged ≥56 Years Clinical Trial
Sign up to get notified when there's something new on the Safety and Immunogenicity of VLA2001 in Adults Aged ≥56 Years Clinical Trial page.

Latest updates to the Safety and Immunogenicity of VLA2001 in Adults Aged ≥56 Years Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.5.5 appears on the page, replacing the previous v3.5.4. This indicates a software release update and affects only the site’s version label in the page footer.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now displays a revised version tag, changing from v3.5.3 to v3.5.4. This is a metadata update indicating the page version and does not modify the study content or results presentation.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page’s displayed site revision/version number was updated from v3.5.2 to v3.5.3. This reflects a site release change rather than any update to the study’s results or details.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check84 days agoChange DetectedFooter revision tag updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Safety and Immunogenicity of VLA2001 in Adults Aged ≥56 Years Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Immunogenicity of VLA2001 in Adults Aged ≥56 Years Clinical Trial page.